These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9784097)

  • 1. In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkages.
    He GX; Williams JP; Postich MJ; Swaminathan S; Shea RG; Terhorst T; Law VS; Mao CT; Sueoka C; Coutré S; Bischofberger N
    J Med Chem; 1998 Oct; 41(22):4224-31. PubMed ID: 9784097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivo.
    He GX; Krawczyk SH; Swaminathan S; Shea RG; Dougherty JP; Terhorst T; Law VS; Griffin LC; Coutré S; Bischofberger N
    J Med Chem; 1998 Jun; 41(13):2234-42. PubMed ID: 9632356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
    Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
    J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis.
    Lu T; Markotan T; Coppo F; Tomczuk B; Crysler C; Eisennagel S; Spurlino J; Gremminger L; Soll RM; Giardino EC; Bone R
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3727-31. PubMed ID: 15203151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary structure peptide mimetics: design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors.
    Boatman PD; Ogbu CO; Eguchi M; Kim HO; Nakanishi H; Cao B; Shea JP; Kahn M
    J Med Chem; 1999 Apr; 42(8):1367-75. PubMed ID: 10212122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
    Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors.
    Obreza A; Stegnar M; Trampus-Bakija A; Prezelj A; Urleb U
    Pharmazie; 2004 Oct; 59(10):739-43. PubMed ID: 15544050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling.
    Steinmetzer T; Baum B; Biela A; Klebe G; Nowak G; Bucha E
    ChemMedChem; 2012 Nov; 7(11):1965-73. PubMed ID: 22907907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel thrombin inhibitors with azaphenylalanine scaffold.
    Zega A; Trampus-Bakija A; Fortuna M; Stegnar M; Tschopp TB; Steiner B; Urleb U
    Pharmazie; 2001 Sep; 56(9):683-5. PubMed ID: 11593985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.
    Lazarova TI; Jin L; Rynkiewicz M; Gorga JC; Bibbins F; Meyers HV; Babine R; Strickler J
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5022-7. PubMed ID: 16876411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives.
    Sall DJ; Bailey DL; Bastian JA; Buben JA; Chirgadze NY; Clemens-Smith AC; Denney ML; Fisher MJ; Giera DD; Gifford-Moore DS; Harper RW; Johnson LM; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Palkowitz AD; Richett ME; Smith GF; Snyder DW; Takeuchi K; Toth JE; Zhang M
    J Med Chem; 2000 Feb; 43(4):649-63. PubMed ID: 10691691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
    Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
    Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
    Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
    Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
    De Simone G; Menchise V; Omaggio S; Pedone C; Scozzafava A; Supuran CT
    Biochemistry; 2003 Aug; 42(30):9013-21. PubMed ID: 12885234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs.
    Young RJ; Borthwick AD; Brown D; Burns-Kurtis CL; Campbell M; Chan C; Charbaut M; Chung CW; Convery MA; Kelly HA; Paul King N; Kleanthous S; Mason AM; Pateman AJ; Patikis AN; Pinto IL; Pollard DR; Senger S; Shah GP; Toomey JR; Watson NS; Weston HE
    Bioorg Med Chem Lett; 2008 Jan; 18(1):23-7. PubMed ID: 18054228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits.
    Griffin LC; Tidmarsh GF; Bock LC; Toole JJ; Leung LL
    Blood; 1993 Jun; 81(12):3271-6. PubMed ID: 8507864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.